Management of Toxicities Associated With ARSi+ADT Therapy in mCSPC

Jochen Walz

ASCO® GU 2024 Insights: "Prognostic Value of FDG, PSMA, and DOTATATE…

Insights from 2024 ASCO® GU Annual Meeting

F. Pouliot

ASCO® GU 2024 Insights: "PROMPT-2 Trial - PSA Response Among Patient…

Insights from 2024 ASCO® GU Annual Meeting

G. Brown

Local Treatment of the Prostate in Synchronous mHSPC

PROSCA & BLADDR 2023

A. Bossi

Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…

Manish Kohli

ESMO 2023 Insights: "Effect of Rapid Ultra-Low Prostate-Specific Ant…

Insights from 2023 ESMO Annual Meeting

A. Merseburger

Theragnostics in Metastatic Prostate Cancer: Diagnosis and Treatment

International Urology Cancer Summit - IUCS

G. Gnanasegaran

New Imaging Technology in Prostate Cancer

Fox Chase Cancer Center

J. Yu